New data shows the number of passengers screened in Canadian airports was much higher for domestic and abroad destinations — ...

Guardant Health (GH) announced the company and its research collaborators will present data showing the critical role of blood-based testing in increasing cancer screening adherence at the American ...

The 5-year lung cancer survival rate has increased more than 25% over the past decade, highlighting the impact of increased ...

Breast cancer is a disease that affects people in different ways, at different times in their lives, and doesn’t start or end ...

A new study has confirmed that the human papillomavirus (HPV) vaccine provides strong and sustained protection against ...

Find out your chances of getting into IIT through JEE Main 2026. Last year, only 16.96% qualified for JEE Advanced. Learn ...

While cancer screening rates varied by body mass index (BMI) category and type, screening rates for Papanicolaou testing, mammography, sigmoidoscopy, and colonoscopy among those with a BMI of 50.0 or ...

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

Clinical trials have shown hormone replacement therapy is effective in slowing down bone loss, preventing fractures and ...

PHOENIX - Exact Sciences Corp. (NASDAQ:EXAS), a $12.24 billion healthcare diagnostics company with a robust financial health score of "GOOD" according to InvestingPro, presented new research at the ...

International student enrollment statistics for fall 2025 have remained consistent in the face of immigration restrictions on ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company and its research collaborators will present data showing the critical role of blood-based testing ...